Search results
Results from the Health.Zone Content Network
Gulf & Fraser is a member-owned financial institution in British Columbia, Canada, with over 61,000 members and 26 branches. It was founded in 1940 and has grown through mergers with other credit unions, including Aldergrove, V.P., Mount Lehman and Interior Savings.
Fraser Health is a regional public health authority in British Columbia, Canada, serving 1.9 million residents. It provides various health care services, including acute care, community care, mental health, and addictions, through 13 hospitals and 110 community sites.
The Fraser Institute is a public policy think tank and charity founded in 1974 by economist Michael Walker and businessman T. Patrick Boyle. It is known for its advocacy of free-market policies and its rankings of economic freedom and quality of life in Canada and worldwide.
Frasers Property is a multinational real estate and property management company that develops, owns, and manages properties across Asia, Europe, and Australia. It was founded in 1963 as Cold Storage Limited and became an independent entity under the TCC Group in 2013.
Johnson served on the boards of the Women's Health Research Institute, the Michael Smith Foundation for Health Research, and Innovate BC. She currently serves on the Board of Directors for Universities Canada. [5] In 2014, she became Simon Fraser University's first female Vice President of Research, [6] succeeding Mario Pinto. [7]
SFSS is the students' union of Simon Fraser University in Metro Vancouver, Canada. It offers services, advocacy, and campaigns for over 26,000 undergraduate students, and has a history of political activism and controversy.
Christopher T. Fraser has served as board director of KMG Chemicals, Inc. since June 2008 and was elected chairman of the board of directors in December 2012. As an operating partner of the global ...
Kenneth Frazier is the executive chairman and former CEO of Merck & Co., the second-largest drug company in the US. He is the first African American man to lead a major pharmaceutical company and has overseen the company's defense against Vioxx litigation and its research on Alzheimer's disease.